(a) A warning for an exposure to delta-9-tetrahydrocannabinol (delta-9-THC) from a cannabis or other consumer product that is intended for dermal application meets the requirements of this subarticle if it complies with the content requirements in Section 25607.45 and is provided using one or more of the methods required in Section 25602, not including subsection (a)(4).

(b) Where a specific sign, label, or shelf tag used to provide a warning for delta-9-THC from a cannabis or other consumer product that is intended for dermal application includes consumer information in a language other than English, the warning must also be provided in that language in addition to English.

(c) Prior to October 1, 2023, a warning for an exposure to delta-9-THC from a cannabis or other consumer product that is intended for dermal application is deemed to be clear and reasonable if it complies with either of the following:

(d) Notwithstanding subsection (a), a warning for an exposure to delta-9-THC from a cannabis or other consumer product that is intended for dermal application that was manufactured prior to October 1, 2023, and that utilizes either of the on-the-label warning methods of transmission set out in subsections (a)(3) and (a)(4) of Section 25602 and complies with the content set out in Section 25603, is deemed to be clear and reasonable regardless of when the product is sold to a consumer.